RACHEAL KEDZE: Open Payments
NPI 1700443736 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$233 in 3 payments from 2 companies in 2025. Trend: 2023 $102 · 2024 $259 · 2025 $233
Food & beverage: $233
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $141 |
| Teva Pharmaceuticals USA, Inc. | 1 | $92 |
Products named: INGREZZA, AUSTEDO XR.
Industry payments across TX — which companies pay providers there.
